Lantheus Holdings, Inc. (NASDAQ: LNTH) related to its sale to Curium US Holdings LLC. Under the terms of the proposed transaction, Lantheus shareholders are expected to receive $102.50 per share in cash, plus non-transferable contingent value rights providing for up to $12.00 per share in potential additional cash payments, subject to achievement of specified commercial milestones for Lantheus’ products through 2030.